companydata.dkcompanydata.dk

ResMed Denmark A/S: Financial statements 2026

CVR: 30699246

Source: annual report 2026, Danish Business Authority

01/07/2025 – 30/06/2026

ResMed Denmark A/S (CVR 30699246) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 27,805,765 and a net result of DKK 8,090,129 compared with DKK 7,641,198 the year before. That is an increase of 2.6% compared with the year before. Equity in the 2026 report amounted to DKK 50,133,405. The solvency ratio was 63.3%.

Gross Profit
DKK 27,805,765
Profit/Loss
DKK 8,090,129
Equity
DKK 50,133,405
Total Assets
DKK 79,231,033
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-27.8M8.1M50.1M0
2025-27.1M7.6M42M0
2024-22M5.9M34.4M20
2023-22M5.8M28.5M19
2022-18.2M3.8M22.7M18

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ResMed Denmark A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

About ResMed Denmark A/S

ResMed Denmark A/S is a Danish company of the type Aktieselskab based in Maribo, founded in 2007. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ResMed Maribo A/S and MARIBO MEDICO A/S. The management consists of Malene Brun Petersen. The board consists of Michael James Rider (chair), Jussi Antero Vuorela, Malene Brun Petersen and Nigel Wayne Robinson. The company is owned by ResMed Sensor Technologies Ltd. The company has 22 employees (2026). In 2026, the company reported a gross profit of DKK 27,805,765 and a net result of DKK 8,090,129 compared with DKK 7,641,198 the year before. Equity in the 2026 report amounted to DKK 50,133,405.

Source: annual report 2026, Danish Business Authority